Orgenesis Inc.
Unlocking the Potential of Cell and Gene Therapy for All (NASDAQ: ORGS)
Germantown, United States
65 employees
Grant
Total: $69.12M
Biotechnology, Health Care +1
General Information
Germantown, United States
BounceWatch is an independent company data service, not affiliated with Orgenesis Inc.. To contact Orgenesis Inc., visit orgenesis.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Orgenesis Inc. compare?
A PDF of Orgenesis Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Orgenesis Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About Orgenesis Inc.
Business keywords: biotech, cell therapy, gene therapy, POCare Network, decentralized production, diabetes treatment, Autologous Insulin Producing (AIP) cell transplantation, beta cell replacement, pancreas islet transplantation, clinical trials, FDA guidelines, molecular and cellular approach, global biotech company, organ regeneration, insulin-dependent diabetes mellitus
Funding Rounds & Investors (9)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | €1.50M | 1 |
Wallonia Regional Government
|
13 Mar 2024 |
| Post IPO Equity | $2.30M | - |
|
04 Mar 2024 |
| Venture Round | $1.00M | - |
|
08 Sep 2023 |
| Post IPO Equity | $35.00M | 1 |
Metalmark Capital
|
07 Nov 2022 |
| Post IPO Equity | Undisclosed | 1 |
|
28 Sep 2021 |
| Post IPO Equity | $16.00M | 1 |
|
01 Feb 2017 |
| Post IPO Equity | $10.00M | - |
|
16 Dec 2015 |
| Grant | $2.02M | - |
|
26 Nov 2014 |
| Post IPO Equity | $1.30M | - |
|
13 May 2013 |
Orgenesis Inc. Alternatives & Competitors
View All Alternatives
ASGCT is the primary membership organization for professionals working in gene and cell therapy.
Momentous change has happened, and a cancer-free future is possible -- thanks to cell and gene thera...
Our mission is to leverage the power of gene and cell therapy to reduce human suffering from serious...
FAQ About Orgenesis Inc.
Source: BounceWatch company record for Orgenesis Inc., https://bouncewatch.com/company/orgenesis-inc, updated 25 November 2024. When citing, please name BounceWatch and link this page.
